• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters1
Displaying 9-23 of 86 results

6 Preliminary Response: Patent Owner Preliminary Response

Document IPR2021-01132, No. 6 Preliminary Response - Patent Owner Preliminary Response (P.T.A.B. Oct. 12, 2021)
Although the Examiner did not expressly address Berge, Gould, or Nyqvist, the Examiner nonetheless considered Petitioner’s arguments with respect to these references.
cite Cite Document
Analyze

3 Mandatory Notice: Patent Owners Mandatory Notices

Document IPR2021-01132, No. 3 Mandatory Notice - Patent Owners Mandatory Notices (P.T.A.B. Jul. 7, 2021)
A Power of Attorney appointing lead and back-up counsel to transact business in this proceeding on behalf of Pfizer Inc. will be submitted concurrently with this Mandatory Notice.
Related Matters Patent Owner is not aware of any judicial or administrative matters that would affect, or be affected by, a decision in this proceeding.
The ’927 patent has been the subject of the following terminated judicial proceedings: • Pfizer Inc. et al. v. Viwit Pharmaceutical Co., Ltd., C.A.
Lead and Backup Counsel Pursuant to 37 C.F.R. § 42.8(b)(3), Patent Owner designates the following lead and backup counsel:
Paper No. 3 Filed: July 7, 2021 _/Michael Liu/___________ Andrew V. Trask (Reg. No. 59,239) Michael Xun Liu (Reg. No: 68,815) Williams & Connolly LLP 725 Twelfth Street NW Washington, D.C. 20005
cite Cite Document
Analyze

2 Power of Attorney: Petitioners Power of Attorney

Document IPR2021-01132, No. 2 Power of Attorney - Petitioners Power of Attorney (P.T.A.B. Jun. 17, 2021)
Log in to see more
cite Cite Document
Analyze

2002 Exhibit: 503 Patent

Document IPR2021-01132, No. 2002-27 Exhibit - 503 Patent (P.T.A.B. Oct. 12, 2021)
Log in to see more
cite Cite Document
Analyze

2001 Exhibit: Chantix Label

Document IPR2021-01132, No. 2001-26 Exhibit - Chantix Label (P.T.A.B. Oct. 12, 2021)
Log in to see more
cite Cite Document
Analyze

2004 Exhibit: PubChem Robalzotan

Document IPR2021-01132, No. 2004-29 Exhibit - PubChem Robalzotan (P.T.A.B. Oct. 12, 2021)
Log in to see more
cite Cite Document
Analyze

2003 Exhibit: EP1078637A2

Document IPR2021-01132, No. 2003-28 Exhibit - EP1078637A2 (P.T.A.B. Oct. 12, 2021)
Log in to see more
cite Cite Document
Analyze

2004 Exhibit: PubChem Robalzotan

Document IPR2021-01132, No. 2004 Exhibit - PubChem Robalzotan (P.T.A.B. Oct. 12, 2021)
Log in to see more
cite Cite Document
Analyze

2002 Exhibit: 503 Patent

Document IPR2021-01132, No. 2002 Exhibit - 503 Patent (P.T.A.B. Oct. 12, 2021)
Log in to see more
cite Cite Document
Analyze

2003 Exhibit: EP1078637A2

Document IPR2021-01132, No. 2003 Exhibit - EP1078637A2 (P.T.A.B. Oct. 12, 2021)

cite Cite Document
Analyze

2001 Exhibit: Chantix Label

Document IPR2021-01132, No. 2001 Exhibit - Chantix Label (P.T.A.B. Oct. 12, 2021)

cite Cite Document
Analyze

1022 Exhibit: Ex 1021 US 6794388

Document IPR2021-01132, No. 1022-22 Exhibit - Ex 1021 US 6794388 (P.T.A.B. Jun. 17, 2021)

cite Cite Document
Analyze

1016 Exhibit: Ex 1015 Bastin

Document IPR2021-01132, No. 1016-16 Exhibit - Ex 1015 Bastin (P.T.A.B. Jun. 17, 2021)

cite Cite Document
Analyze

1009 Exhibit: Ex 1008 CA 2467490

Document IPR2021-01132, No. 1009-9 Exhibit - Ex 1008 CA 2467490 (P.T.A.B. Jun. 17, 2021)

cite Cite Document
Analyze

1021 Exhibit: Ex 1020 US 2870198

Document IPR2021-01132, No. 1021-21 Exhibit - Ex 1020 US 2870198 (P.T.A.B. Jun. 17, 2021)

cite Cite Document
Analyze
<< 1 2 3 4 5 6 7 >>